These results, together with a earlier report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 help the concept of targeting ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-linked disorders. A investigate examine published in Anesthesiology https://johny991zxr8.blogproducer.com/profile